Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer

This study is currently recruiting participants.

Verified February 2013 by National Cancer Institute (NCI)

Study NCT00430183 Information provided by National Cancer Institute (NCI)

First Received on January 30, 2007. Last Updated on February 19, 2013 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Prostate Cancer

Additional conditions recognized in this trial

Prostatic Neoplasms

More general conditions related to this trial

Interventions listed in this trial

Additional drug interventions recognized in this trial

Goserelin
Leuprolide

More general drug interventions related to this trial

Sponsors listed in this trial